SMTL ID : 8par.1

Crystal structure of human MAP4K1 with an inhibitor, BAY-405

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 4 residues within 4Å: Chain A: P.215, L.216, P.236, R.237 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:L.216, A:R.237

1 x XON: ~{N}-[3,5-bis(fluoranyl)-4-[[3-[1-(trifluoromethyl)cyclopropyl]-1~{H}-pyrrolo[2,3-b]pyridin-4-yl]oxy]phenyl]-2,9-dioxa-4-azaspiro[5.5]undec-3-en-3-amine

XON.2: 16 residues within 4Å: Chain A: L.24, G.25, G.26, Y.29, V.32, A.45, K.47, V.76, M.92, E.93, F.94, C.95, D.102, L.145, A.155, F.157 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:Y.29, A:A.45, A:L.145, A:A.155 Hydrogen bonds: A:C.95, A:D.102 pi-Stacking: A:Y.29

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mowat, J. et al., Identification and optimization of Azaindole based MAP4K1 Inhibitors and the discovery of BAY-405. To Be Published

Release Date

2024-06-26

Peptides

Mitogen-activated protein kinase kinase kinase kinase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase kinase kinase kinase 1